Aimed Bio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	29,651	11,760	171.21	111.09
Revenue Growth (YoY)	17218.10%	6768.70%	54.12%	-
Gross Profit	29,651	11,760	171.21	111.09
Selling, General & Admin	20,076	10,704	5,529	4,922
Amortization of Goodwill & Intangibles	284.6	120.25	64.32	49.76
Operating Expenses	21,853	12,168	6,588	5,703
Operating Income	7,798	-407.75	-6,416	-5,592
Interest Expense	-50.81	-93.11	-119.08	-123.26
Interest & Investment Income	1,462	1,117	207.22	162.72
Currency Exchange Gain (Loss)	-522.01	89.94	7.27	60.6
Other Non Operating Income (Expenses)	-50,780	-4,116	-1,617	11.45
EBT Excluding Unusual Items	-42,092	-3,411	-7,938	-5,480
Gain (Loss) on Sale of Investments	-936.75	96.75	-1,084	-716.25
Gain (Loss) on Sale of Assets	-0.66	0.66	-7.24	-12.95
Pretax Income	-43,029	-3,313	-9,030	-6,210
Earnings From Continuing Operations	-43,029	-3,313	-9,030	-6,210
Minority Interest in Earnings	8.65	9.28	6.95	41.03
Net Income	-43,021	-3,304	-9,023	-6,168
Net Income to Common	-43,021	-3,304	-9,023	-6,168
Shares Outstanding (Basic)	40	35	34	33
Shares Outstanding (Diluted)	40	35	34	33
Shares Change (YoY)	18.19%	3.86%	2.16%	-
EPS (Basic)	-1065.74	-93.14	-264.18	-184.51
EPS (Diluted)	-1065.74	-93.14	-264.18	-184.51
Free Cash Flow	26,561	-5,098	-3,440	-4,360
Free Cash Flow Per Share	657.98	-143.71	-100.72	-130.42
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Margin	26.30%	-3.47%	-3747.54%	-5033.36%
Profit Margin	-145.09%	-28.09%	-5269.87%	-5552.44%
Free Cash Flow Margin	89.58%	-43.35%	-2009.11%	-3924.65%
EBITDA	9,203	1,056	-5,358	-4,811
EBITDA Margin	31.04%	8.98%	-	-
D&A For EBITDA	1,405	1,464	1,058	780.45
EBIT	7,798	-407.75	-6,416	-5,592
EBIT Margin	26.30%	-3.47%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.